Seeking Alpha

DATROWAY® Granted Priority Review in the U.S. as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who Are Not Candidates for Immunotherapy

Based on results from TROPION-Breast02 showing Daiichi Sankyo and AstraZeneca’ s DATROWAY significantly improved overall survival versus chemotherapy in this patient population If approved, DATROWAY ...